<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34360544</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>15</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>21</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7781</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22157781</ELocationID><Abstract><AbstractText>The abnormal mislocalisation and ubiquitinated protein aggregation of the TAR DNA binding protein 43 (TDP-43) within the cytoplasm of neurons and glia in the central nervous system (CNS) is a pathological hallmark of early-onset neurodegenerative disorders amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The pathomechanisms underlying abnormal mislocalisation and aggregation of TDP-43 remain unknown. However, there is a growing body of evidence implicating neuroinflammation and immune-mediated mechanisms in the pathogenesis of neurodegeneration. Importantly, most of the evidence for an active role of immunity and inflammation in the pathogenesis of ALS and FTD relates specifically to TDP-43, posing the question as to whether immune-mediated mechanisms could hold the key to understanding TDP-43's underlying role in neurodegeneration in both diseases. Therefore, this review aims to piece together key lines of evidence for the specific association of TDP-43 with key immune and inflammatory pathways to explore the nature of this relationship and the implications for potential pathomechanisms underlying neurodegeneration in ALS and FTD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bright</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-1255-2350</Identifier><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Biomedical Science, Faculty of Medicine Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Biomedical Science, Faculty of Medicine Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Hummel</LastName><ForeName>Annika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Biomedical Science, Faculty of Medicine Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ittner</LastName><ForeName>Lars M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Biomedical Science, Faculty of Medicine Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Yazi D</ForeName><Initials>YD</Initials><Identifier Source="ORCID">0000-0002-1423-0451</Identifier><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Biomedical Science, Faculty of Medicine Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34360544</ArticleId><ArticleId IdType="pmc">PMC8346169</ArticleId><ArticleId IdType="doi">10.3390/ijms22157781</ArticleId><ArticleId IdType="pii">ijms22157781</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease&#x2014;A double-edged sword. Neuron. 2002;35:419&#x2013;432. doi: 10.1016/S0896-6273(02)00794-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00794-8</ArticleId><ArticleId IdType="pubmed">12165466</ArticleId></ArticleIdList></Reference><Reference><Citation>Sochocka M., Diniz B.S., Leszek J. Inflammatory Response in the CNS: Friend or Foe? Mol. Neurobiol. 2017;54:8071&#x2013;8089. doi: 10.1007/s12035-016-0297-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0297-1</ArticleId><ArticleId IdType="pmc">PMC5684251</ArticleId><ArticleId IdType="pubmed">27889895</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo L., Prather E.R., Stetskiv M., Garrison D.E., Meade J.R., Peace T.I., Zhou T. Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments. Int. J. Mol. Sci. 2019;20:4472. doi: 10.3390/ijms20184472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184472</ArticleId><ArticleId IdType="pmc">PMC6769561</ArticleId><ArticleId IdType="pubmed">31510091</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Dan X., Babbar M., Wei Y., Hasselbalch S.G., Croteau D.L., Bohr V.A. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 2019;15:565&#x2013;581. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Golenbock D.T., Latz E. Innate immunity in Alzheimer&#x2019;s disease. Nat. Immunol. 2015;16:229&#x2013;236. doi: 10.1038/ni.3102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3102</ArticleId><ArticleId IdType="pubmed">25689443</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., Baloh R.H. Inflammation in ALS/FTD pathogenesis. Acta. Neuropathol. 2019;137:715&#x2013;730. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Bright F., Werry E.L., Dobson-Stone C., Piguet O., Ittner L.M., Halliday G.M., Hodges J.R., Kiernan M.C., Loy C.T., Kassiou M., et al. Neuroinflammation in frontotemporal dementia. Nat. Rev. Neurol. 2019;15:540&#x2013;555. doi: 10.1038/s41582-019-0231-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0231-z</ArticleId><ArticleId IdType="pubmed">31324897</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese V., Santoro A., Monti D., Crupi R., Di Paola R., Latteri S., Cuzzocrea S., Zappia M., Giordano J., Calabrese E.J., et al. Aging and Parkinson&#x2019;s Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol. Med. 2018;115:80&#x2013;91. doi: 10.1016/j.freeradbiomed.2017.10.379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.10.379</ArticleId><ArticleId IdType="pubmed">29080843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou S.H., Wu F., Harrich D., Garcia-Martinez L.F., Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 1995;69:3584&#x2013;3596. doi: 10.1128/jvi.69.6.3584-3596.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.6.3584-3596.1995</ArticleId><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A., Conicella A.E., Schmidt H.B., Martin E.W., Rhoads S.N., Reeb A.N., Nourse A., Ramirez Montero D., Ryan V.H., Rohatgi R., et al. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 2018;37:e97452. doi: 10.15252/embj.201797452.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797452</ArticleId><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Mompean M., Romano V., Pantoja-Uceda D., Stuani C., Baralle F.E., Buratti E., Laurents D.V. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions. J. Biol. Chem. 2017;292:11992&#x2013;12006. doi: 10.1074/jbc.M117.775965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.775965</ArticleId><ArticleId IdType="pmc">PMC5512090</ArticleId><ArticleId IdType="pubmed">28566288</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Baralle F.E. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci. 2008;13:867&#x2013;878. doi: 10.2741/2727.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2727</ArticleId><ArticleId IdType="pubmed">17981595</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Baralle F.E. TDP-43: Gumming up neurons through protein-protein and protein-RNA interactions. Trends Biochem. Sci. 2012;37:237&#x2013;247. doi: 10.1016/j.tibs.2012.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2012.03.003</ArticleId><ArticleId IdType="pubmed">22534659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercado P.A., Ayala Y.M., Romano M., Buratti E., Baralle F.E. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res. 2005;33:6000&#x2013;6010. doi: 10.1093/nar/gki897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki897</ArticleId><ArticleId IdType="pmc">PMC1270946</ArticleId><ArticleId IdType="pubmed">16254078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hefferon T.W., Groman J.D., Yurk C.E., Cutting G.R. A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing. Proc. Natl. Acad. Sci. USA. 2004;101:3504&#x2013;3509. doi: 10.1073/pnas.0400182101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0400182101</ArticleId><ArticleId IdType="pmc">PMC373492</ArticleId><ArticleId IdType="pubmed">14993601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H., Funk C., Abou-Ajram C., Hutten S., Funk E.B.E., Kehlenbach R.H., Bailer S.M., Dormann D. Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1. Sci. Rep. 2018;8:7084. doi: 10.1038/s41598-018-25007-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25007-5</ArticleId><ArticleId IdType="pmc">PMC5935713</ArticleId><ArticleId IdType="pubmed">29728564</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinarbasi E.S., Cagatay T., Fung H.Y.J., Li Y.C., Chook Y.M., Thomas P.J. Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization. Sci. Rep. 2018;8:7083. doi: 10.1038/s41598-018-25008-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25008-4</ArticleId><ArticleId IdType="pmc">PMC5935693</ArticleId><ArticleId IdType="pubmed">29728608</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold H.C., Jackson K.L., Arora A., Weskamp K., Tank E.M., Li X., Miguez R., Dayton R.D., Tamir S., Klein R.L., et al. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci. Rep. 2018;8:4606. doi: 10.1038/s41598-018-22858-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22858-w</ArticleId><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Good S.K., Atkin S., Dewey C.M., Mayer P., 3rd, Herz J., Yu G. TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem. 2010;285:6826&#x2013;6834. doi: 10.1074/jbc.M109.061846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.061846</ArticleId><ArticleId IdType="pmc">PMC2825476</ArticleId><ArticleId IdType="pubmed">20040602</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J.F., Majumder P., Chatterjee B., Huang S.L., Shen C.J. TDP-43 Regulates Coupled Dendritic mRNA Transport-Translation Processes in Co-operation with FMRP and Staufen1. Cell Rep. 2019;29:3118&#x2013;3133. doi: 10.1016/j.celrep.2019.10.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.10.061</ArticleId><ArticleId IdType="pubmed">31801077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y.M., De Conti L., Avendano-Vazquez S.E., Dhir A., Romano M., D&#x2019;Ambrogio A., Tollervey J., Ule J., Baralle M., Buratti E., et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011;30:277&#x2013;288. doi: 10.1038/emboj.2010.310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.310</ArticleId><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., McCaffery J.M., Lindquist S., Gitler A.D. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA. 2008;105:6439&#x2013;6444. doi: 10.1073/pnas.0802082105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802082105</ArticleId><ArticleId IdType="pmc">PMC2359814</ArticleId><ArticleId IdType="pubmed">18434538</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer B.C., Schuck T., Wheeler J.M., Robinson L.C., Trojanowski J.Q., Lee V.M., Schellenberg G.D. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta. Neuropathol. 2010;119:409&#x2013;419. doi: 10.1007/s00401-010-0659-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0659-0</ArticleId><ArticleId IdType="pmc">PMC2880609</ArticleId><ArticleId IdType="pubmed">20198480</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt A., Herholz D., Fiesel F.C., Kaur K., Muller D., Karsten P., Weber S.S., Kahle P.J., Marquardt T., Schulz J.B. TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS ONE. 2010;5:e12247. doi: 10.1371/journal.pone.0012247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012247</ArticleId><ArticleId IdType="pmc">PMC2923622</ArticleId><ArticleId IdType="pubmed">20806063</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibiger C., Deisel J., Aufschnaiter A., Ambros S., Tereshchenko M., Verheijen B.M., Buttner S., Braun R.J. TDP-43 controls lysosomal pathways thereby determining its own clearance and cytotoxicity. Hum. Mol. Genet. 2018;27:1593&#x2013;1607. doi: 10.1093/hmg/ddy066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy066</ArticleId><ArticleId IdType="pubmed">29474575</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.K., Chiang M.H., Toh E.K., Chang C.F., Huang T.H. Molecular mechanism of oxidation-induced TDP-43 RRM1 aggregation and loss of function. FEBS Lett. 2013;587:575&#x2013;582. doi: 10.1016/j.febslet.2013.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2013.01.038</ArticleId><ArticleId IdType="pubmed">23384725</ArticleId></ArticleIdList></Reference><Reference><Citation>Shodai A., Morimura T., Ido A., Uchida T., Ayaki T., Takahashi R., Kitazawa S., Suzuki S., Shirouzu M., Kigawa T., et al. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43) J. Biol. Chem. 2013;288:14886&#x2013;14905. doi: 10.1074/jbc.M113.451849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.451849</ArticleId><ArticleId IdType="pmc">PMC3663511</ArticleId><ArticleId IdType="pubmed">23558684</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnier C., Devred F., Byrne D., Puppo R., Roman A.Y., Malesinski S., Golovin A.V., Lebrun R., Ninkina N.N., Tsvetkov P.O. Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates. Sci. Rep. 2017;7:6812. doi: 10.1038/s41598-017-07215-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07215-7</ArticleId><ArticleId IdType="pmc">PMC5533730</ArticleId><ArticleId IdType="pubmed">28754988</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacco E., Grana-Montes R., Martin S.R., de Groot N.S., Alfano C., Tartaglia G.G., Pastore A. RNA as a key factor in driving or preventing self-assembly of the TAR DNA-binding protein 43. J. Mol. Biol. 2019;431:1671&#x2013;1688. doi: 10.1016/j.jmb.2019.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.01.028</ArticleId><ArticleId IdType="pmc">PMC6461199</ArticleId><ArticleId IdType="pubmed">30742796</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. TDP-43 post-translational modifications in health and disease. Expert Opin. Ther. Targets. 2018;22:279&#x2013;293. doi: 10.1080/14728222.2018.1439923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2018.1439923</ArticleId><ArticleId IdType="pubmed">29431050</ArticleId></ArticleIdList></Reference><Reference><Citation>Francois-Moutal L., Perez-Miller S., Scott D.D., Miranda V.G., Mollasalehi N., Khanna M. Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Front. Mol. Neurosci. 2019;12:301. doi: 10.3389/fnmol.2019.00301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00301</ArticleId><ArticleId IdType="pmc">PMC6934062</ArticleId><ArticleId IdType="pubmed">31920533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Xu Y.F., Cook C., Gendron T.F., Roettges P., Link C.D., Lin W.L., Tong J., Castanedes-Casey M., Ash P., et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA. 2009;106:7607&#x2013;7612. doi: 10.1073/pnas.0900688106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900688106</ArticleId><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning B.A., Walker A.K. The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD. Front. Neurosci. 2019;13:335. doi: 10.3389/fnins.2019.00335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00335</ArticleId><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan R.H., Kril J.J., Fatima M., McGeachie A., McCann H., Shepherd C., Forrest S.L., Affleck A., Kwok J.B., Hodges J.R., et al. TDP-43 proteinopathies: Pathological identification of brain regions differentiating clinical phenotypes. Brain. 2015;138:3110&#x2013;3122. doi: 10.1093/brain/awv220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv220</ArticleId><ArticleId IdType="pubmed">26231953</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P., Hendrich C., Sperfeld A.D., Jesse S., von Arnim C.A., Lehnert S., Pabst A., Uttner I., Tumani H., Lee V.M., et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch. Neurol. 2008;65:1481&#x2013;1487. doi: 10.1001/archneur.65.11.1481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.11.1481</ArticleId><ArticleId IdType="pmc">PMC2690860</ArticleId><ArticleId IdType="pubmed">19001167</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F., Lee V.M., Trojanowski J.Q. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: A spectrum of TDP-43 proteinopathies. Neuropathology. 2010;30:103&#x2013;112. doi: 10.1111/j.1440-1789.2009.01091.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2009.01091.x</ArticleId><ArticleId IdType="pmc">PMC3131978</ArticleId><ArticleId IdType="pubmed">20102519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai T., Tokuda T., Ishigami N., Sasayama H., Foulds P., Mitchell D.J., Mann D.M., Allsop D., Nakagawa M. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta. Neuropathol. 2009;117:55&#x2013;62. doi: 10.1007/s00401-008-0456-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0456-1</ArticleId><ArticleId IdType="pubmed">18989684</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohn T.T. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer&#x2019;s disease. Brain Res. 2008;1228:189&#x2013;198. doi: 10.1016/j.brainres.2008.06.094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2008.06.094</ArticleId><ArticleId IdType="pmc">PMC2565865</ArticleId><ArticleId IdType="pubmed">18634762</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakashima-Yasuda H., Uryu K., Robinson J., Xie S.X., Hurtig H., Duda J.E., Arnold S.E., Siderowf A., Grossman M., Leverenz J.B., et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta. Neuropathol. 2007;114:221&#x2013;229. doi: 10.1007/s00401-007-0261-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0261-2</ArticleId><ArticleId IdType="pubmed">17653732</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab C., Arai T., Hasegawa M., Yu S., McGeer P.L. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J. Neuropathol. Exp. Neurol. 2008;67:1159&#x2013;1165. doi: 10.1097/NEN.0b013e31818e8951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31818e8951</ArticleId><ArticleId IdType="pubmed">19018245</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee A.C., Stein T.D., Kiernan P.T., Alvarez V.E. The neuropathology of chronic traumatic encephalopathy. Brain Pathol. 2015;25:350&#x2013;364. doi: 10.1111/bpa.12248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12248</ArticleId><ArticleId IdType="pmc">PMC4526170</ArticleId><ArticleId IdType="pubmed">25904048</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Daniels C.M., Goldman J.E., Trojanowski J.Q., Lee V.M., Messing A. Astrocytic TDP-43 pathology in Alexander disease. J. Neurosci. 2014;34:6448&#x2013;6458. doi: 10.1523/JNEUROSCI.0248-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0248-14.2014</ArticleId><ArticleId IdType="pmc">PMC4012304</ArticleId><ArticleId IdType="pubmed">24806671</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu E.A., Mori E., Hamasaki F., Lieberman A.P. TDP-43 proteinopathy occurs independently of autophagic substrate accumulation and underlies nuclear defects in Niemann-Pick C disease. Neuropathol. Appl. Neurobiol. 2021 doi: 10.1111/nan.12738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12738</ArticleId><ArticleId IdType="pubmed">34048071</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Ren Y., Perkerson R.B., 3rd, Baker M., Jenkins G.D., van Blitterswijk M., DeJesus-Hernandez M., van Rooij J.G.J., Murray M.E., Christopher E., et al. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. Acta Neuropathol. 2019;137:879&#x2013;899. doi: 10.1007/s00401-019-01962-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01962-9</ArticleId><ArticleId IdType="pmc">PMC6533145</ArticleId><ArticleId IdType="pubmed">30739198</ArticleId></ArticleIdList></Reference><Reference><Citation>Broce I., Karch C.M., Wen N., Fan C.C., Wang Y., Tan C.H., Kouri N., Ross O.A., Hoglinger G.U., Muller U., et al. Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies. PLoS Med. 2018;15:e1002487. doi: 10.1371/journal.pmed.1002487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002487</ArticleId><ArticleId IdType="pmc">PMC5760014</ArticleId><ArticleId IdType="pubmed">29315334</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H., Kleinberger G., Janssens J., Pereson S., Joris G., Cuijt I., Smits V., Ceuterick-de Groote C., Van Broeckhoven C., Kumar-Singh S. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA. 2010;107:3858&#x2013;3863. doi: 10.1073/pnas.0912417107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0912417107</ArticleId><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R.C., Jawaid A., Henstridge C.M., Valeri A., Merlini M., Robinson J.L., Lee E.B., Rose J., Appel S., Lee V.M., et al. TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss. Neuron. 2017;95:297&#x2013;308. doi: 10.1016/j.neuron.2017.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.05.037</ArticleId><ArticleId IdType="pmc">PMC5519492</ArticleId><ArticleId IdType="pubmed">28669544</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudria-Lopez E., Koppers M., de Wit M., van der Meer C., Westeneng H.J., Zundel C.A., Youssef S.A., Harkema L., de Bruin A., Veldink J.H., et al. Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta. Neuropathol. 2016;132:145&#x2013;147. doi: 10.1007/s00401-016-1581-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1581-x</ArticleId><ArticleId IdType="pmc">PMC4911370</ArticleId><ArticleId IdType="pubmed">27206760</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Suzuki N., Wang J.Y., Moccia R., Mordes D.A., Stewart M.H., Suzuki-Uematsu S., Ghosh S., Singh A., Merkle F.T., et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 2016;8:347ra393. doi: 10.1126/scitranslmed.aaf6038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A., Decman V., White D., Ramos M., Ikiz B., Lee H.C., Siao C.J., Brydges S., LaRosa E., Bai Y., et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci. Rep. 2016;6:23204. doi: 10.1038/srep23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurner L., Preuss K.D., Fadle N., Regitz E., Klemm P., Zaks M., Kemele M., Hasenfus A., Csernok E., Gross W.L., et al. Progranulin antibodies in autoimmune diseases. J. Autoimmun. 2013;42:29&#x2013;38. doi: 10.1016/j.jaut.2012.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2012.10.003</ArticleId><ArticleId IdType="pubmed">23149338</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurner L., Fadle N., Regitz E., Kemele M., Klemm P., Zaks M., Stoger E., Bette B., Carbon G., Zimmer V., et al. The molecular basis for development of proinflammatory autoantibodies to progranulin. J. Autoimmun. 2015;61:17&#x2013;28. doi: 10.1016/j.jaut.2015.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.05.002</ArticleId><ArticleId IdType="pubmed">26005049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad L., Zhang S.Y., Casanova J.L., Sancho-Shimizu V. Human TBK1: A Gatekeeper of Neuroinflammation. Trends Mol. Med. 2016;22:511&#x2013;527. doi: 10.1016/j.molmed.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4890605</ArticleId><ArticleId IdType="pubmed">27211305</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003;4:491&#x2013;496. doi: 10.1038/ni921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni921</ArticleId><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V., Dutta K., Phaneuf D., Sobue G., Julien J.P. Ubiquilin-2 drives NF-kappaB activity and cytosolic TDP-43 aggregation in neuronal cells. Mol. Brain. 2015;8:71. doi: 10.1186/s13041-015-0162-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0162-6</ArticleId><ArticleId IdType="pmc">PMC4628361</ArticleId><ArticleId IdType="pubmed">26521126</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R., Bett J.S., Keuss M.J., Solovyova A., McWilliams T.G., Johnson C., Sahu I., Varghese J., Wood N., Wightman M., et al. UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. Cell. 2016;166:935&#x2013;949. doi: 10.1016/j.cell.2016.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.07.001</ArticleId><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao T.P., Kolaitis R.M., Kim H.J., O&#x2019;Donovan K., Martyniak B., Colicino E., Hehnly H., Taylor J.P., Castaneda C.A. Ubiquitin Modulates Liquid-Liquid Phase Separation of UBQLN2 via Disruption of Multivalent Interactions. Mol. Cell. 2018;69:965&#x2013;978. doi: 10.1016/j.molcel.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.02.004</ArticleId><ArticleId IdType="pmc">PMC6181577</ArticleId><ArticleId IdType="pubmed">29526694</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe R., Higashi S., Nonaka T., Kawakami I., Oshima K., Niizato K., Akiyama H., Yoshida M., Hasegawa M., Arai T. Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions. Acta. Neuropathol. Commun. 2020;8:176. doi: 10.1186/s40478-020-01055-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01055-9</ArticleId><ArticleId IdType="pmc">PMC7594343</ArticleId><ArticleId IdType="pubmed">33115537</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoles D.R., Dansithong W., Pflieger L.T., Paul S., Gandelman M., Figueroa K.P., Rigo F., Bennett C.F., Pulst S.M. ALS-associated genes in SCA2 mouse spinal cord transcriptomes. Hum. Mol. Genet. 2020;29:1658&#x2013;1672. doi: 10.1093/hmg/ddaa072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa072</ArticleId><ArticleId IdType="pmc">PMC7322574</ArticleId><ArticleId IdType="pubmed">32307524</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieber M.W., Jaenisch N., Brehm M., Guenther M., Linnartz-Gerlach B., Neumann H., Witte O.W., Frahm C. Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke. PLoS ONE. 2013;8:e52982. doi: 10.1371/journal.pone.0052982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052982</ArticleId><ArticleId IdType="pmc">PMC3536811</ArticleId><ArticleId IdType="pubmed">23301011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawabori M., Kacimi R., Kauppinen T., Calosing C., Kim J.Y., Hsieh C.L., Nakamura M.C., Yenari M.A. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J. Neurosci. 2015;35:3384&#x2013;3396. doi: 10.1523/JNEUROSCI.2620-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2620-14.2015</ArticleId><ArticleId IdType="pmc">PMC4339351</ArticleId><ArticleId IdType="pubmed">25716838</ArticleId></ArticleIdList></Reference><Reference><Citation>Saber M., Kokiko-Cochran O., Puntambekar S.S., Lathia J.D., Lamb B.T. Triggering Receptor Expressed on Myeloid Cells 2 Deficiency Alters Acute Macrophage Distribution and Improves Recovery after Traumatic Brain Injury. J. Neurotrauma. 2017;34:423&#x2013;435. doi: 10.1089/neu.2016.4401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2016.4401</ArticleId><ArticleId IdType="pubmed">26976047</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., De Jager P.L., Yang J., Trojanowski J.Q., Bennett D.A., Schneider J.A. The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Neurology. 2015;84:927&#x2013;934. doi: 10.1212/WNL.0000000000001313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001313</ArticleId><ArticleId IdType="pmc">PMC4351662</ArticleId><ArticleId IdType="pubmed">25653292</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinn H., Abeliovich A. Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes. Cell Syst. 2017;4:404&#x2013;415. doi: 10.1016/j.cels.2017.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2017.02.009</ArticleId><ArticleId IdType="pubmed">28330615</ArticleId></ArticleIdList></Reference><Reference><Citation>Osawa T., Mizuno Y., Fujita Y., Takatama M., Nakazato Y., Okamoto K. Optineurin in neurodegenerative diseases. Neuropathology. 2011;31:569&#x2013;574. doi: 10.1111/j.1440-1789.2011.01199.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2011.01199.x</ArticleId><ArticleId IdType="pubmed">21284751</ArticleId></ArticleIdList></Reference><Reference><Citation>Slowicka K., van Loo G. Optineurin Functions for Optimal Immunity. Front. Immunol. 2018;9:769. doi: 10.3389/fimmu.2018.00769.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00769</ArticleId><ArticleId IdType="pmc">PMC5902560</ArticleId><ArticleId IdType="pubmed">29692786</ArticleId></ArticleIdList></Reference><Reference><Citation>Meena N.P., Zhu G., Mittelstadt P.R., Giardino Torchia M.L., Pourcelot M., Arnoult D., Ashwell J.D., Munitic I. The TBK1-binding domain of optineurin promotes type I interferon responses. FEBS Lett. 2016;590:1498&#x2013;1508. doi: 10.1002/1873-3468.12176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12176</ArticleId><ArticleId IdType="pmc">PMC4879041</ArticleId><ArticleId IdType="pubmed">27086836</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew T.S., O&#x2019;Shea N.R., Sewell G.W., Oehlers S.H., Mulvey C.M., Crosier P.S., Godovac-Zimmermann J., Bloom S.L., Smith A.M., Segal A.W. Optineurin deficiency in mice contributes to impaired cytokine secretion and neutrophil recruitment in bacteria-driven colitis. Dis. Model. Mech. 2015;8:817&#x2013;829. doi: 10.1242/dmm.020362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.020362</ArticleId><ArticleId IdType="pmc">PMC4527293</ArticleId><ArticleId IdType="pubmed">26044960</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Strom A.L., Kwinter D.M., Kilty R., Zhang J., Shi P., Fu W., Wooten M.W., Zhu H. Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J. Neurochem. 2009;111:1062&#x2013;1073. doi: 10.1111/j.1471-4159.2009.06388.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06388.x</ArticleId><ArticleId IdType="pmc">PMC2766427</ArticleId><ArticleId IdType="pubmed">19765191</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz L., Sanchez P., Lallena M.J., Diaz-Meco M.T., Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO J. 1999;18:3044&#x2013;3053. doi: 10.1093/emboj/18.11.3044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.11.3044</ArticleId><ArticleId IdType="pmc">PMC1171386</ArticleId><ArticleId IdType="pubmed">10356400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratz M., Coats B.R., Hisert K.B., Hagman D., Mutskov V., Peris E., Schoenfelt K.Q., Kuzma J.N., Larson I., Billing P.S., et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab. 2014;20:614&#x2013;625. doi: 10.1016/j.cmet.2014.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2014.08.010</ArticleId><ArticleId IdType="pmc">PMC4192131</ArticleId><ArticleId IdType="pubmed">25242226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho M.A., Strider J., Carter D., Taylor-Reinwald L., Forman M.S., Goate A.M., Cairns N.J. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J. Biol. Chem. 2009;284:12384&#x2013;12398. doi: 10.1074/jbc.M900992200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M900992200</ArticleId><ArticleId IdType="pmc">PMC2673306</ArticleId><ArticleId IdType="pubmed">19237541</ArticleId></ArticleIdList></Reference><Reference><Citation>Dec E., Rana P., Katheria V., Dec R., Khare M., Nalbandian A., Leu S.Y., Radom-Aizik S., Llewellyn K., BenMohamed L., et al. Cytokine profiling in patients with VCP-associated disease. Clin. Transl. Sci. 2014;7:29&#x2013;32. doi: 10.1111/cts.12117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12117</ArticleId><ArticleId IdType="pmc">PMC4057603</ArticleId><ArticleId IdType="pubmed">24119107</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Khan A.A., Srivastava R., Llewellyn K.J., Tan B., Shukr N., Fazli Y., Kimonis V.E., BenMohamed L. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy. Inflammation. 2017;40:21&#x2013;41. doi: 10.1007/s10753-016-0449-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-016-0449-5</ArticleId><ArticleId IdType="pmc">PMC5800525</ArticleId><ArticleId IdType="pubmed">27730320</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson-Stone C., Hallupp M., Shahheydari H., Ragagnin A.M.G., Chatterton Z., Carew-Jones F., Shepherd C.E., Stefen H., Paric E., Fath T., et al. CYLD is a causative gene for frontotemporal dementia-amyotrophic lateral sclerosis. Brain. 2020;143:783&#x2013;799. doi: 10.1093/brain/awaa039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa039</ArticleId><ArticleId IdType="pmc">PMC7089666</ArticleId><ArticleId IdType="pubmed">32185393</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Lee A.J., Wu X., Sun S.C. Regulation of antiviral innate immunity by deubiquitinase CYLD. Cell. Mol. Immunol. 2011;8:502&#x2013;504. doi: 10.1038/cmi.2011.42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2011.42</ArticleId><ArticleId IdType="pmc">PMC3210422</ArticleId><ArticleId IdType="pubmed">21946435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., Courtois G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature. 2003;424:801&#x2013;805. doi: 10.1038/nature01802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01802</ArticleId><ArticleId IdType="pubmed">12917691</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C.N., Wu Y., Odeh H.M., Gendron T.F., Jansen-West K., Del Rosso G., Yue M., Jiang P., Gomes E., Tong J., et al. C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci. Transl. Med. 2020;12:559. doi: 10.1126/scitranslmed.abb3774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abb3774</ArticleId><ArticleId IdType="pmc">PMC7989020</ArticleId><ArticleId IdType="pubmed">32878979</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredi M., Cavazzana I., Biasiotto G., Filosto M., Padovani A., Monti E., Tincani A., Franceschini F., Zanella I. C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis. Neuromol. Med. 2019;21:150&#x2013;159. doi: 10.1007/s12017-019-08528-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-019-08528-8</ArticleId><ArticleId IdType="pubmed">30859373</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Burberry A., Wang J.Y., Sandoe J., Ghosh S., Udeshi N.D., Svinkina T., Mordes D.A., Mok J., Charlton M., et al. The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis. Genes. Dev. 2018;32:929&#x2013;943. doi: 10.1101/gad.313932.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.313932.118</ArticleId><ArticleId IdType="pmc">PMC6075033</ArticleId><ArticleId IdType="pubmed">29950492</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Yanez A., Lall D., Wolf A.J., Muhammad A.K., Ho R., Carmona S., Vit J.P., Zarrow J., et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D., Baloh R.H. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J. Clin. Investig. 2017;127:3250&#x2013;3258. doi: 10.1172/JCI90607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90607</ArticleId><ArticleId IdType="pmc">PMC5669558</ArticleId><ArticleId IdType="pubmed">28737506</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostalski H., Leskela S., Huber N., Katisko K., Cajanus A., Solje E., Marttinen M., Natunen T., Remes A.M., Hiltunen M., et al. Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS. Front. Neurosci. 2019;13:486. doi: 10.3389/fnins.2019.00486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00486</ArticleId><ArticleId IdType="pmc">PMC6529740</ArticleId><ArticleId IdType="pubmed">31156371</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Baker M., Pickering-Brown S., Hsiung G.Y., Lindholm C., Dwosh E., Gass J., Cannon A., Rademakers R., Hutton M., et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain. 2006;129:3081&#x2013;3090. doi: 10.1093/brain/awl271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl271</ArticleId><ArticleId IdType="pubmed">17071926</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916&#x2013;919. doi: 10.1038/nature05016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05016</ArticleId><ArticleId IdType="pubmed">16862116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee O., Pastor P., Cairns N.J., Chakraverty S., Kauwe J.S., Shears S., Behrens M.I., Budde J., Hinrichs A.L., Norton J., et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann. Neurol. 2006;60:314&#x2013;322. doi: 10.1002/ana.20963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20963</ArticleId><ArticleId IdType="pmc">PMC2803024</ArticleId><ArticleId IdType="pubmed">16983685</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickford F., Marcus J., Camargo L.M., Xiao Q., Graham D., Mo J.R., Burkhardt M., Kulkarni V., Crispino J., Hering H., et al. Progranulin is a chemoattractant for microglia and stimulates their endocytic activity. Am. J. Pathol. 2011;178:284&#x2013;295. doi: 10.1016/j.ajpath.2010.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2010.11.002</ArticleId><ArticleId IdType="pmc">PMC3070582</ArticleId><ArticleId IdType="pubmed">21224065</ArticleId></ArticleIdList></Reference><Reference><Citation>Townley R.A., Boeve B.F., Benarroch E.E. Progranulin: Functions and neurologic correlations. Neurology. 2018;90:118&#x2013;125. doi: 10.1212/WNL.0000000000004840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004840</ArticleId><ArticleId IdType="pmc">PMC5772162</ArticleId><ArticleId IdType="pubmed">29263224</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.J., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920&#x2013;924. doi: 10.1038/nature05017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05017</ArticleId><ArticleId IdType="pubmed">16862115</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanesi E., Bonvicini C., Alberici A., Pilotto A., Cattane N., Premi E., Gazzina S., Archetti S., Gasparotti R., Cancelli V., et al. Molecular signature of disease onset in granulin mutation carriers: A gene expression analysis study. Neurobiol. Aging. 2013;34:1837&#x2013;1845. doi: 10.1016/j.neurobiolaging.2012.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.11.016</ArticleId><ArticleId IdType="pubmed">23419701</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y., Matsuwaki T., Yamanouchi K., Nishihara M. Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice. Neuroscience. 2013;250:8&#x2013;19. doi: 10.1016/j.neuroscience.2013.06.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.06.049</ArticleId><ArticleId IdType="pubmed">23830905</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens L.H., Zhang J., Barmada S.J., Zhou P., Kamiya S., Sun B., Min S.W., Gan L., Finkbeiner S., Huang E.J., et al. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J. Clin. Investig. 2012;122:3955&#x2013;3959. doi: 10.1172/JCI63113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI63113</ArticleId><ArticleId IdType="pmc">PMC3484443</ArticleId><ArticleId IdType="pubmed">23041626</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin F., Banerjee R., Thomas B., Zhou P., Qian L., Jia T., Ma X., Ma Y., Iadecola C., Beal M.F., et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J. Exp. Med. 2010;207:117&#x2013;128. doi: 10.1084/jem.20091568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20091568</ArticleId><ArticleId IdType="pmc">PMC2812536</ArticleId><ArticleId IdType="pubmed">20026663</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M., Modeste E., Dammer E., Merino P., Taylor G., Duong D.M., Deng Q., Holler C.J., Gearing M., Dickson D., et al. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations. Acta. Neuropathol. Commun. 2020;8:163. doi: 10.1186/s40478-020-01037-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01037-x</ArticleId><ArticleId IdType="pmc">PMC7541308</ArticleId><ArticleId IdType="pubmed">33028409</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui H., Zhang J., Makinson S.R., Cahill M.K., Kelley K.W., Huang H.Y., Shang Y., Oldham M.C., Martens L.H., Gao F., et al. Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. Cell. 2016;165:921&#x2013;935. doi: 10.1016/j.cell.2016.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.001</ArticleId><ArticleId IdType="pmc">PMC4860138</ArticleId><ArticleId IdType="pubmed">27114033</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Bieniek K.F., Finch N., van de Vorst M., Baker M., Perkersen R., Brown P., Ravenscroft T., van Blitterswijk M., Nicholson A.M., et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta. Neuropathol. 2015;130:77&#x2013;92. doi: 10.1007/s00401-015-1436-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1436-x</ArticleId><ArticleId IdType="pmc">PMC4470809</ArticleId><ArticleId IdType="pubmed">25943890</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.F., Wang Q., Krueger B.J., et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., Muller K., Marroquin N., Nordin F., Hubers A., Weydt P., et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J., Gijselinck I., Van Mossevelde S., Perrone F., Dillen L., Heeman B., Baumer V., Engelborghs S., De Bleecker J., Baets J., et al. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Hum. Mutat. 2017;38:297&#x2013;309. doi: 10.1002/humu.23161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23161</ArticleId><ArticleId IdType="pmc">PMC5324646</ArticleId><ArticleId IdType="pubmed">28008748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P., Farhan H., McEwan D.G., Wagner S., Rogov V.V., Brady N.R., Richter B., Korac J., Waidmann O., Choudhary C., et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333:228&#x2013;233. doi: 10.1126/science.1205405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1205405</ArticleId><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilli M., Arko-Mensah J., Ponpuak M., Roberts E., Master S., Mandell M.A., Dupont N., Ornatowski W., Jiang S., Bradfute S.B., et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity. 2012;37:223&#x2013;234. doi: 10.1016/j.immuni.2012.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.04.015</ArticleId><ArticleId IdType="pmc">PMC3428731</ArticleId><ArticleId IdType="pubmed">22921120</ArticleId></ArticleIdList></Reference><Reference><Citation>Salminen A., Huuskonen J., Ojala J., Kauppinen A., Kaarniranta K., Suuronen T. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res. Rev. 2008;7:83&#x2013;105. doi: 10.1016/j.arr.2007.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2007.09.002</ArticleId><ArticleId IdType="pubmed">17964225</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounatidis I., Chtarbanova S., Cao Y., Hayne M., Jayanth D., Ganetzky B., Ligoxygakis P. NF-kappaB Immunity in the Brain Determines Fly Lifespan in Healthy Aging and Age-Related Neurodegeneration. Cell Rep. 2017;19:836&#x2013;848. doi: 10.1016/j.celrep.2017.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.04.007</ArticleId><ArticleId IdType="pmc">PMC5413584</ArticleId><ArticleId IdType="pubmed">28445733</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z.R., Li Y.X., Lei H.Y., Yang D.Q., Wang L.Q., Luo M.Y. Regulating effect of activated NF-kappaB on edema induced by traumatic brain injury of rats. Asian Pac. J. Trop. Med. 2016;9:274&#x2013;277. doi: 10.1016/j.apjtm.2016.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apjtm.2016.01.027</ArticleId><ArticleId IdType="pubmed">26972401</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivandzade F., Prasad S., Bhalerao A., Cucullo L. NRF2 and NF-B interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches. Redox Biol. 2019;21:101059. doi: 10.1016/j.redox.2018.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.11.017</ArticleId><ArticleId IdType="pmc">PMC6302038</ArticleId><ArticleId IdType="pubmed">30576920</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhang L., Joo D., Sun S.C. NF-kappaB signaling in inflammation. Signal. Transduct. Target. Ther. 2017;2:1&#x2013;9. doi: 10.1038/sigtrans.2017.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia A.S., Patel P., Dutta K., Julien J.P. Inflammation Induces TDP-43 Mislocalization and Aggregation. PLoS ONE. 2015;10:e0140248. doi: 10.1371/journal.pone.0140248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140248</ArticleId><ArticleId IdType="pmc">PMC4596857</ArticleId><ArticleId IdType="pubmed">26444430</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Bell S., Wang J., Wen S., Baloh R.H., Appel S.H. TDP-43 activates microglia through NF-kappaB and NLRP3 inflammasome. Exp. Neurol. 2015;273:24&#x2013;35. doi: 10.1016/j.expneurol.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.07.019</ArticleId><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K., Thammisetty S.S., Boutej H., Bareil C., Julien J.P. Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling. J. Neurosci. 2020;40:5137&#x2013;5154. doi: 10.1523/JNEUROSCI.0536-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0536-20.2020</ArticleId><ArticleId IdType="pmc">PMC7314413</ArticleId><ArticleId IdType="pubmed">32457070</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Cynader M.S., Jia W. TDP-43 Inhibits NF-kappaB Activity by Blocking p65 Nuclear Translocation. PLoS ONE. 2015;10:e0142296. doi: 10.1371/journal.pone.0142296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142296</ArticleId><ArticleId IdType="pmc">PMC4646651</ArticleId><ArticleId IdType="pubmed">26571498</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V., Phaneuf D., Dupre N., Petri S., Strong M., Kriz J., Julien J.P. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J. Exp. Med. 2011;208:2429&#x2013;2447. doi: 10.1084/jem.20111313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi S., Thammisetty S.S., Codron P., Rahimian R., Plourde K.V., Soucy G., Bareil C., Phaneuf D., Kriz J., Gravel C., et al. Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology. J. Clin. Investig. 2019;129:1581&#x2013;1595. doi: 10.1172/JCI123931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI123931</ArticleId><ArticleId IdType="pmc">PMC6436898</ArticleId><ArticleId IdType="pubmed">30667370</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Huntley M.L., Perry G., Wang X. Pathomechanisms of TDP-43 in neurodegeneration. J. Neurochem. 2018;146:7&#x2013;20. doi: 10.1111/jnc.14327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14327</ArticleId><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Y.D., van Hummel A., Stevens C.H., Gladbach A., Ippati S., Bi M., Lee W.S., Kruger S., van der Hoven J., Volkerling A., et al. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathol. 2015;130:661&#x2013;678. doi: 10.1007/s00401-015-1486-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1486-0</ArticleId><ArticleId IdType="pubmed">26437864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y., Tremblay C., Schneider J.A., Bennett D.A., Calon F., Julien J.P. Interaction of transactive response DNA binding protein 43 with nuclear factor kappaB in mild cognitive impairment with episodic memory deficits. Acta Neuropathol. Commun. 2014;2:37. doi: 10.1186/2051-5960-2-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-37</ArticleId><ArticleId IdType="pmc">PMC4230634</ArticleId><ArticleId IdType="pubmed">24690380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallstig E., McCabe B.D., Schneider B.L. The Links between ALS and NF-kappaB. Int. J. Mol. Sci. 2021;22:3875. doi: 10.3390/ijms22083875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22083875</ArticleId><ArticleId IdType="pmc">PMC8070122</ArticleId><ArticleId IdType="pubmed">33918092</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Snyder S.H., Bohr V.A. Signaling by cGAS-STING in Neurodegeneration, Neuroinflammation, and Aging. Trends Neurosci. 2021;44:83&#x2013;96. doi: 10.1016/j.tins.2020.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.10.008</ArticleId><ArticleId IdType="pubmed">33187730</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.H., Davidson S., Harapas C.R., Hilton J.B., Mlodzianoski M.J., Laohamonthonkul P., Louis C., Low R.R.J., Moecking J., De Nardo D., et al. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. Cell. 2020;183:636&#x2013;649. doi: 10.1016/j.cell.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrane J., Cortez C., Gan W.B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Zhao W. NLRP3 Inflammasome-A Key Player in Antiviral Responses. Front. Immunol. 2020;11:211. doi: 10.3389/fimmu.2020.00211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00211</ArticleId><ArticleId IdType="pmc">PMC7040071</ArticleId><ArticleId IdType="pubmed">32133002</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Hara H., Nunez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem. Sci. 2016;41:1012&#x2013;1021. doi: 10.1016/j.tibs.2016.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2016.09.002</ArticleId><ArticleId IdType="pmc">PMC5123939</ArticleId><ArticleId IdType="pubmed">27669650</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L., Pei L., Yao S., Wu Y., Shang Y. NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies. Front. Cell. Neurosci. 2017;11:63. doi: 10.3389/fncel.2017.00063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00063</ArticleId><ArticleId IdType="pmc">PMC5343070</ArticleId><ArticleId IdType="pubmed">28337127</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadhim H., Deltenre P., Martin J.J., Sebire G. In-situ expression of Interleukin-18 and associated mediators in the human brain of sALS patients: Hypothesis for a role for immune-inflammatory mechanisms. Med. Hypotheses. 2016;86:14&#x2013;17. doi: 10.1016/j.mehy.2015.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2015.11.022</ArticleId><ArticleId IdType="pubmed">26804591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang J., Wen X., Zhang Y.Q., Shan Q., Zhang Z.F., Zheng G.H., Fan S.H., Li M.Q., Wu D.M., Hu B., et al. TDP-43 upregulation mediated by the NLRP3 inflammasome induces cognitive impairment in 2 2&#x2019;,4,4&#x2019;-tetrabromodiphenyl ether (BDE-47)-treated mice. Brain Behav. Immun. 2017;65:99&#x2013;110. doi: 10.1016/j.bbi.2017.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2017.05.014</ArticleId><ArticleId IdType="pubmed">28532818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliter D.A., Martinez J., Hao L., Chen X., Sun N., Fischer T.D., Burman J.L., Li Y., Zhang Z., Narendra D.P., et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature. 2018;561:258&#x2013;262. doi: 10.1038/s41586-018-0448-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0448-9</ArticleId><ArticleId IdType="pmc">PMC7362342</ArticleId><ArticleId IdType="pubmed">30135585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebron M.L., Lonskaya I., Sharpe K., Weerasinghe P.P., Algarzae N.K., Shekoyan A.R., Moussa C.E. Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6) J. Biol. Chem. 2013;288:4103&#x2013;4115. doi: 10.1074/jbc.M112.419945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.419945</ArticleId><ArticleId IdType="pmc">PMC3567661</ArticleId><ArticleId IdType="pubmed">23258539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenqiang C., Lonskaya I., Hebron M.L., Ibrahim Z., Olszewski R.T., Neale J.H., Moussa C.E. Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice. Hum. Mol. Genet. 2014;23:4960&#x2013;4969. doi: 10.1093/hmg/ddu211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu211</ArticleId><ArticleId IdType="pubmed">24847002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Duan Y., Qin C., Li J.C., Duan G., Deng X., Ni J., Cao X., Xiang K., Tian K., et al. Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy. Cell Death Dis. 2018;9:953. doi: 10.1038/s41419-018-1022-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1022-y</ArticleId><ArticleId IdType="pmc">PMC6148241</ArticleId><ArticleId IdType="pubmed">30237395</ArticleId></ArticleIdList></Reference><Reference><Citation>Deora V., Lee J.D., Albornoz E.A., McAlary L., Jagaraj C.J., Robertson A.A.B., Atkin J.D., Cooper M.A., Schroder K., Yerbury J.J., et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 2020;68:407&#x2013;421. doi: 10.1002/glia.23728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23728</ArticleId><ArticleId IdType="pubmed">31596526</ArticleId></ArticleIdList></Reference><Reference><Citation>Trageser K.J., Smith C., Herman F.J., Ono K., Pasinetti G.M. Mechanisms of Immune Activation by c9orf72-Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2019;13:1298. doi: 10.3389/fnins.2019.01298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01298</ArticleId><ArticleId IdType="pmc">PMC6914852</ArticleId><ArticleId IdType="pubmed">31920478</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Vandoorne T., Steyaert J., Staats K.A., Van Den Bosch L. The multifaceted role of kinases in amyotrophic lateral sclerosis: Genetic, pathological and therapeutic implications. Brain. 2020;143:1651&#x2013;1673. doi: 10.1093/brain/awaa022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa022</ArticleId><ArticleId IdType="pmc">PMC7296858</ArticleId><ArticleId IdType="pubmed">32206784</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes J.A., Davies M.C., Collins M.O. TBK1: A new player in ALS linking autophagy and neuroinflammation. Mol. Brain. 2017;10:5. doi: 10.1186/s13041-017-0287-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Asih P.R., Prikas E., Stefanoska K., Tan A.R.P., Ahel H.I., Ittner A. Functions of p38 MAP Kinases in the Central Nervous System. Front. Mol. Neurosci. 2020;13:570586. doi: 10.3389/fnmol.2020.570586.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.570586</ArticleId><ArticleId IdType="pmc">PMC7509416</ArticleId><ArticleId IdType="pubmed">33013322</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan L., Xie Q., Tibbetts R.S. Opposing roles of p38 and JNK in a Drosophila model of TDP-43 proteinopathy reveal oxidative stress and innate immunity as pathogenic components of neurodegeneration. Hum. Mol. Genet. 2015;24:757&#x2013;772. doi: 10.1093/hmg/ddu493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu493</ArticleId><ArticleId IdType="pmc">PMC4291250</ArticleId><ArticleId IdType="pubmed">25281658</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis. Lancet Neurol. 2008;7:409&#x2013;416. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Zhang Z.F., Qin F.W., Tang W., Liu D.H., Wu P.Y., Jiao F. The mechanism of TDP-43 gene expression on inflammatory factors and the JNK and p38 MAPK signalling pathways in ischaemic hypoxic stress dependence. Int. Wound J. 2019;16:724&#x2013;729. doi: 10.1111/iwj.13087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iwj.13087</ArticleId><ArticleId IdType="pmc">PMC7949179</ArticleId><ArticleId IdType="pubmed">30784197</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff T.M., Costantini K.J., Crane J.W., Atkin J.D., Monk P.N., Taylor S.M., Noakes P.G. The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J. Immunol. 2008;181:8727&#x2013;8734. doi: 10.4049/jimmunol.181.12.8727.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.12.8727</ArticleId><ArticleId IdType="pubmed">19050293</ArticleId></ArticleIdList></Reference><Reference><Citation>Sta M., Sylva-Steenland R.M., Casula M., de Jong J.M., Troost D., Aronica E., Baas F. Innate and adaptive immunity in amyotrophic lateral sclerosis: Evidence of complement activation. Neurobiol. Dis. 2011;42:211&#x2013;220. doi: 10.1016/j.nbd.2011.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.01.002</ArticleId><ArticleId IdType="pubmed">21220013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.D., Levin S.C., Willis E.F., Li R., Woodruff T.M., Noakes P.G. Complement components are upregulated and correlate with disease progression in the TDP-43(Q331K) mouse model of amyotrophic lateral sclerosis. J. Neuroinflamm. 2018;15:171. doi: 10.1186/s12974-018-1217-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1217-2</ArticleId><ArticleId IdType="pmc">PMC5984816</ArticleId><ArticleId IdType="pubmed">29859100</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephan A.H., Barres B.A., Stevens B. The complement system: An unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 2012;35:369&#x2013;389. doi: 10.1146/annurev-neuro-061010-113810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-061010-113810</ArticleId><ArticleId IdType="pubmed">22715882</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyburn L., Hebron M.L., Smith J., Winston C., Bechara J., Li Z., Lonskaya I., Burns M.P., Harris B.T., Moussa C.E. Tyrosine kinase inhibition reverses TDP-43 effects on synaptic protein expression, astrocytic function and amino acid dis-homeostasis. J. Neurochem. 2016;139:610&#x2013;623. doi: 10.1111/jnc.13763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13763</ArticleId><ArticleId IdType="pubmed">27507246</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Yu G. The function of RNA-binding proteins at the synapse: Implications for neurodegeneration. Cell. Mol. Life Sci. 2015;72:3621&#x2013;3635. doi: 10.1007/s00018-015-1943-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-015-1943-x</ArticleId><ArticleId IdType="pmc">PMC4565867</ArticleId><ArticleId IdType="pubmed">26047658</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux J.C., Wang L., Li K., Bright A.T., Alaynick W.A., Williams K.R., Powell S.B., Naviaux R.K. Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model. Mol. Autism. 2015;6:1. doi: 10.1186/2040-2392-6-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2040-2392-6-1</ArticleId><ArticleId IdType="pmc">PMC4334917</ArticleId><ArticleId IdType="pubmed">25705365</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Velmeshev D., Hashimoto K., Huang Y.H., Hofmann J.W., Shi X., Chen J., Leidal A.M., Dishart J.G., Cahill M.K., et al. Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency. Nature. 2020;588:459&#x2013;465. doi: 10.1038/s41586-020-2709-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2709-7</ArticleId><ArticleId IdType="pmc">PMC7746606</ArticleId><ArticleId IdType="pubmed">32866962</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller Z.A., Rankin K.P., Graff-Radford N.R., Takada L.T., Sturm V.E., Cleveland C.M., Criswell L.A., Jaeger P.A., Stan T., Heggeli K.A., et al. TDP-43 frontotemporal lobar degeneration and autoimmune disease. J. Neurol. Neurosurg. Psychiatry. 2013;84:956&#x2013;962. doi: 10.1136/jnnp-2012-304644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304644</ArticleId><ArticleId IdType="pmc">PMC3840954</ArticleId><ArticleId IdType="pubmed">23543794</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller Z.A., Sturm V.E., Camsari G.B., Karydas A., Yokoyama J.S., Grinberg L.T., Boxer A.L., Rosen H.J., Rankin K.P., Gorno-Tempini M.L., et al. Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts: Completing the picture. Neurol. Neuroimmunol. Neuroinflamm. 2016;3:e301. doi: 10.1212/NXI.0000000000000301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000301</ArticleId><ArticleId IdType="pmc">PMC5087253</ArticleId><ArticleId IdType="pubmed">27844039</ArticleId></ArticleIdList></Reference><Reference><Citation>Katisko K., Solje E., Koivisto A.M., Kruger J., Kinnunen T., Hartikainen P., Helisalmi S., Korhonen V., Herukka S.K., Haapasalo A., et al. Prevalence of immunological diseases in a Finnish frontotemporal lobar degeneration cohort with the C9orf72 repeat expansion carriers and non-carriers. J. Neuroimmunol. 2018;321:29&#x2013;35. doi: 10.1016/j.jneuroim.2018.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2018.05.011</ArticleId><ArticleId IdType="pubmed">29957385</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan Y., Sullivan P.M., Hu F. SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasis. Autophagy. 2019;15:871&#x2013;885. doi: 10.1080/15548627.2019.1569914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1569914</ArticleId><ArticleId IdType="pmc">PMC6526807</ArticleId><ArticleId IdType="pubmed">30696333</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian J., Li G., Hettinghouse A., Liu C. Progranulin: A key player in autoimmune diseases. Cytokine. 2018;101:48&#x2013;55. doi: 10.1016/j.cyto.2016.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2016.08.007</ArticleId><ArticleId IdType="pmc">PMC5303690</ArticleId><ArticleId IdType="pubmed">27527809</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurner L., Stoger E., Fadle N., Klemm P., Regitz E., Kemele M., Bette B., Held G., Dauer M., Lammert F., et al. Proinflammatory progranulin antibodies in inflammatory bowel diseases. Dig. Dis. Sci. 2014;59:1733&#x2013;1742. doi: 10.1007/s10620-014-3089-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-014-3089-3</ArticleId><ArticleId IdType="pubmed">24591016</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaraj R.L., Azimullah S., Beiram R., Jalal F.Y., Rosenberg G.A. Neuroinflammation: Friend and foe for ischemic stroke. J. Neuroinflamm. 2019;16:142. doi: 10.1186/s12974-019-1516-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1516-2</ArticleId><ArticleId IdType="pmc">PMC6617684</ArticleId><ArticleId IdType="pubmed">31291966</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.B., Lee V.M., Trojanowski J.Q., Neumann M. TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system. Acta. Neuropathol. 2008;115:305&#x2013;311. doi: 10.1007/s00401-007-0331-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0331-5</ArticleId><ArticleId IdType="pubmed">18087705</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanazawa M., Kakita A., Igarashi H., Takahashi T., Kawamura K., Takahashi H., Nakada T., Nishizawa M., Shimohata T. Biochemical and histopathological alterations in TAR DNA-binding protein-43 after acute ischemic stroke in rats. J. Neurochem. 2011;116:957&#x2013;965. doi: 10.1111/j.1471-4159.2010.06860.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06860.x</ArticleId><ArticleId IdType="pubmed">20557425</ArticleId></ArticleIdList></Reference><Reference><Citation>Thammisetty S.S., Pedragosa J., Weng Y.C., Calon F., Planas A., Kriz J. Age-related deregulation of TDP-43 after stroke enhances NF-kappaB-mediated inflammation and neuronal damage. J. Neuroinflamm. 2018;15:312. doi: 10.1186/s12974-018-1350-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1350-y</ArticleId><ArticleId IdType="pmc">PMC6230239</ArticleId><ArticleId IdType="pubmed">30413172</ArticleId></ArticleIdList></Reference><Reference><Citation>He T., Zuo Y., Ai-Zakwani K., Luo J., Zhu H., Yan X.X., Liu F. Subarachnoid hemorrhage enhances the expression of TDP-43 in the brain of experimental rats and human subjects. Exp. Ther. Med. 2018;16:3363&#x2013;3368. doi: 10.3892/etm.2018.6636.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6636</ArticleId><ArticleId IdType="pmc">PMC6143865</ArticleId><ArticleId IdType="pubmed">30233682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahl A., Blanco I., Jackman K., Baskar J., Milaganur Mohan H., Rodney-Sandy R., Zhang S., Iadecola C., Hochrainer K. Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases. Sci. Rep. 2018;8:2701. doi: 10.1038/s41598-018-21063-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21063-z</ArticleId><ArticleId IdType="pmc">PMC5807442</ArticleId><ArticleId IdType="pubmed">29426953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M., Yamashita T., Shang J., Liu N., Deguchi K., Liu W., Ikeda Y., Feng J., Abe K. Acceleration of TDP43 and FUS/TLS protein expressions in the preconditioned hippocampus following repeated transient ischemia. J. Neurosci. Res. 2014;92:54&#x2013;63. doi: 10.1002/jnr.23301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23301</ArticleId><ArticleId IdType="pubmed">24265138</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow K., Hardy J., Zetterberg H. The neuropathology and neurobiology of traumatic brain injury. Neuron. 2012;76:886&#x2013;899. doi: 10.1016/j.neuron.2012.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.11.021</ArticleId><ArticleId IdType="pubmed">23217738</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee A.C., Gavett B.E., Stern R.A., Nowinski C.J., Cantu R.C., Kowall N.W., Perl D.P., Hedley-Whyte E.T., Price B., Sullivan C., et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 2010;69:918&#x2013;929. doi: 10.1097/NEN.0b013e3181ee7d85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181ee7d85</ArticleId><ArticleId IdType="pmc">PMC2951281</ArticleId><ArticleId IdType="pubmed">20720505</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee A.C., Robinson M.E. Military-related traumatic brain injury and neurodegeneration. Alzheimers Dement. 2014;10:S242&#x2013;S253. doi: 10.1016/j.jalz.2014.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.04.003</ArticleId><ArticleId IdType="pmc">PMC4255273</ArticleId><ArticleId IdType="pubmed">24924675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney K., Iacono D., Edlow B.L., Katz D.I., Diaz-Arrastia R., Dams-O&#x2019;Connor K., Daneshvar D.H., Stevens A., Moreau A.L., Tirrell L.S., et al. Dementia After Moderate-Severe Traumatic Brain Injury: Coexistence of Multiple Proteinopathies. J. Neuropathol. Exp. Neurol. 2018;77:50&#x2013;63. doi: 10.1093/jnen/nlx101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlx101</ArticleId><ArticleId IdType="pmc">PMC5939622</ArticleId><ArticleId IdType="pubmed">29155947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.K., Lee Y.C., Huang C.Y., Liliang P.C., Lu K., Chen H.J., Li Y.C., Tsai K.J. Traumatic brain injury causes frontotemporal dementia and TDP-43 proteolysis. Neuroscience. 2015;300:94&#x2013;103. doi: 10.1016/j.neuroscience.2015.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.05.013</ArticleId><ArticleId IdType="pubmed">25982564</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.Y., Lee Y.C., Li P.C., Liliang P.C., Lu K., Wang K.W., Chang L.C., Shiu L.Y., Chen M.F., Sun Y.T., et al. TDP-43 proteolysis is associated with astrocyte reactivity after traumatic brain injury in rodents. J. Neuroimmunol. 2017;313:61&#x2013;68. doi: 10.1016/j.jneuroim.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2017.10.011</ArticleId><ArticleId IdType="pubmed">29153610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Teng Z., Song Y., Hu M., Chen C. Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury. J. Cereb. Blood Flow Metab. 2015;35:706. doi: 10.1038/jcbfm.2014.247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2014.247</ArticleId><ArticleId IdType="pmc">PMC4420888</ArticleId><ArticleId IdType="pubmed">25826320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesner D., Tar L., Linkus B., Chandrasekar A., Olde Heuvel F., Dupuis L., Tsao W., Wong P.C., Ludolph A., Roselli F. Reversible induction of TDP-43 granules in cortical neurons after traumatic injury. Exp. Neurol. 2018;299:15&#x2013;25. doi: 10.1016/j.expneurol.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.09.011</ArticleId><ArticleId IdType="pubmed">28941811</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyburn L., Sajja V., Long J.B. The Role of TDP-43 in Military-Relevant TBI and Chronic Neurodegeneration. Front. Neurol. 2019;10:680. doi: 10.3389/fneur.2019.00680.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00680</ArticleId><ArticleId IdType="pmc">PMC6610302</ArticleId><ArticleId IdType="pubmed">31316455</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson E.N., Gochenaur L., Singh A., Grant R., Patel K., Watkins S., Wu J.Y., Pandey U.B. Traumatic injury induces stress granule formation and enhances motor dysfunctions in ALS/FTD models. Hum. Mol. Genet. 2018;27:1366&#x2013;1381. doi: 10.1093/hmg/ddy047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy047</ArticleId><ArticleId IdType="pmc">PMC6455923</ArticleId><ArticleId IdType="pubmed">29432563</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson E.N., Morera A.A., Kour S., Cherry J.D., Ramesh N., Gleixner A., Schwartz J.C., Ebmeier C., Old W., Donnelly C.J., et al. Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology. eLife. 2021;10:e67587. doi: 10.7554/eLife.67587.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.67587</ArticleId><ArticleId IdType="pmc">PMC8169113</ArticleId><ArticleId IdType="pubmed">34060470</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>